Apotheek Els De Smedt SRL
Apotheek Els De Smedt reported total assets of 157,911 € at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Jun 2026).
The score of Apotheek Els De Smedt shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +48 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Els De Smedt's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Jun 2026
- Year ended 31 Dec 2024filed on 27 May 2025
- Year ended 31 Dec 2023filed on 23 May 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Apotheek Els De Smedt's financial analysis
- Solvency2.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Els De Smedt
Apotheek Els De Smedt's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0452.653.171
- VAT number
- BE0452653171
- Peppol
- Registered · 0208:0452653171 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 May 1994
- Registered office
- 2070 Beveren-Kruibeke-Zwijndrecht
- Latest accounts
- 2025 · filed on 05 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Els De Smedt (SRL) has been based in Beveren-Kruibeke-Zwijndrecht since 1994, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 2,258 € and equity of 4,533 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Els De Smedt
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Bousval Retail sale of pharmaceutical products Genappe · balance sheet 139,616 €
- Monsoon Retail sale of pharmaceutical products Ghent · balance sheet 157,805 €
- Phamalimo Retail sale of pharmaceutical products Seneffe · balance sheet 159,435 €
- London Pharma Retail sale of pharmaceutical products Ixelles · balance sheet 161,051 €
- Jovaphar Retail sale of pharmaceutical products Middelkerke · balance sheet 154,803 €
- By Nature Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 154,196 €
- Benoît Schleich Retail sale of pharmaceutical products Péruwelz · balance sheet 163,952 €
- Clement Pharma Services Retail sale of pharmaceutical products Meise · balance sheet 151,301 €
Frequently asked questions about Apotheek Els De Smedt
What is the revenue of Apotheek Els De Smedt?
Apotheek Els De Smedt files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Els De Smedt?
In Belgium, the VAT number is the company number prefixed with BE: BE0452653171 for Apotheek Els De Smedt, if the company is VAT-registered. Its company number (CBE) is 0452.653.171.
Where is the registered office of Apotheek Els De Smedt?
According to the CBE register, the registered office of Apotheek Els De Smedt is in 2070 Beveren-Kruibeke-Zwijndrecht.
What is the equity of Apotheek Els De Smedt?
At the close of the 2025 financial year, the equity of Apotheek Els De Smedt amounts to 4,533 €, a solvency of 2.9% of total assets.
Who manages Apotheek Els De Smedt?
The register lists 3 active mandates at Apotheek Els De Smedt. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Els De Smedt
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →